614 related articles for article (PubMed ID: 17329300)
1. Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat.
Abdul-Monim Z; Neill JC; Reynolds GP
J Psychopharmacol; 2007 Mar; 21(2):198-205. PubMed ID: 17329300
[TBL] [Abstract][Full Text] [Related]
2. The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm.
Abdul-Monim Z; Reynolds GP; Neill JC
Behav Brain Res; 2006 May; 169(2):263-73. PubMed ID: 16500717
[TBL] [Abstract][Full Text] [Related]
3. Disturbances in social interaction occur along with pathophysiological deficits following sub-chronic phencyclidine administration in the rat.
Jenkins TA; Harte MK; McKibben CE; Elliott JJ; Reynolds GP
Behav Brain Res; 2008 Dec; 194(2):230-5. PubMed ID: 18706451
[TBL] [Abstract][Full Text] [Related]
4. Effect of subchronic phencyclidine administration on sucrose preference and hippocampal parvalbumin immunoreactivity in the rat.
Jenkins TA; Harte MK; Reynolds GP
Neurosci Lett; 2010 Mar; 471(3):144-7. PubMed ID: 20097262
[TBL] [Abstract][Full Text] [Related]
5. Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.
McKibben CE; Jenkins TA; Adams HN; Harte MK; Reynolds GP
Behav Brain Res; 2010 Mar; 208(1):132-6. PubMed ID: 19914297
[TBL] [Abstract][Full Text] [Related]
6. D(1)-like receptor activation improves PCP-induced cognitive deficits in animal models: Implications for mechanisms of improved cognitive function in schizophrenia.
McLean SL; Idris NF; Woolley ML; Neill JC
Eur Neuropsychopharmacol; 2009 Jun; 19(6):440-50. PubMed ID: 19268547
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics attenuate a sub-chronic PCP-induced cognitive deficit in the novel object recognition task in the rat.
Grayson B; Idris NF; Neill JC
Behav Brain Res; 2007 Nov; 184(1):31-8. PubMed ID: 17675172
[TBL] [Abstract][Full Text] [Related]
8. Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.
Pedersen CS; Goetghebeur P; Dias R
J Neurosci Methods; 2009 Dec; 185(1):66-9. PubMed ID: 19761795
[TBL] [Abstract][Full Text] [Related]
9. Effects of phencyclidine on auditory gating in the rat hippocampus and the medial prefrontal cortex.
Dissanayake DW; Zachariou M; Marsden CA; Mason R
Brain Res; 2009 Nov; 1298():153-60. PubMed ID: 19699183
[TBL] [Abstract][Full Text] [Related]
10. Rapid cortico-limbic alterations in AMPA receptor densities after administration of PCP: implications for schizophrenia.
Zavitsanou K; Nguyen V; Newell K; Ballantyne P; Huang XF
J Chem Neuroanat; 2008 Oct; 36(2):71-6. PubMed ID: 18640263
[TBL] [Abstract][Full Text] [Related]
11. Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs.
Cochran SM; Kennedy M; McKerchar CE; Steward LJ; Pratt JA; Morris BJ
Neuropsychopharmacology; 2003 Feb; 28(2):265-75. PubMed ID: 12589379
[TBL] [Abstract][Full Text] [Related]
12. Clozapine but not haloperidol treatment reverses sub-chronic phencyclidine-induced disruption of conditional discrimination performance.
Dunn MJ; Killcross S
Behav Brain Res; 2006 Dec; 175(2):271-7. PubMed ID: 17027093
[TBL] [Abstract][Full Text] [Related]
13. Effects of repeated phencyclidine administration on adult hippocampal neurogenesis in the rat.
Liu J; Suzuki T; Seki T; Namba T; Tanimura A; Arai H
Synapse; 2006 Jul; 60(1):56-68. PubMed ID: 16596623
[TBL] [Abstract][Full Text] [Related]
14. Activation of α7 nicotinic receptors improves phencyclidine-induced deficits in cognitive tasks in rats: implications for therapy of cognitive dysfunction in schizophrenia.
McLean SL; Grayson B; Idris NF; Lesage AS; Pemberton DJ; Mackie C; Neill JC
Eur Neuropsychopharmacol; 2011 Apr; 21(4):333-43. PubMed ID: 20630711
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of GABA(A) receptor subunit mRNAs and ligand binding sites in rat brain following phencyclidine administration.
Abe S; Suzuki T; Ito T; Baba A; Hori T; Kurita H; Yamaguchi M; Shiraishi H
Synapse; 2000 Oct; 38(1):51-60. PubMed ID: 10941140
[TBL] [Abstract][Full Text] [Related]
16. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats.
Rodefer JS; Murphy ER; Baxter MG
Eur J Neurosci; 2005 Feb; 21(4):1070-6. PubMed ID: 15787711
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of parvalbumin in neonatal phencyclidine-treated rats and socially isolated rats.
Kaalund SS; Riise J; Broberg BV; Fabricius K; Karlsen AS; Secher T; Plath N; Pakkenberg B
J Neurochem; 2013 Feb; 124(4):548-57. PubMed ID: 23083323
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
19. Behavioural effects of neonatal lesions of the medial prefrontal cortex and subchronic pubertal treatment with phencyclidine of adult rats.
Schwabe K; Klein S; Koch M
Behav Brain Res; 2006 Mar; 168(1):150-60. PubMed ID: 16387372
[TBL] [Abstract][Full Text] [Related]
20. Effects of risperidone, clozapine and the 5-HT6 antagonist GSK-742457 on PCP-induced deficits in reversal learning in the two-lever operant task in male Sprague Dawley rats.
de Bruin NM; van Drimmelen M; Kops M; van Elk J; Wetering MM; Schwienbacher I
Behav Brain Res; 2013 May; 244():15-28. PubMed ID: 23384714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
